NCT00251433 GW572016 With Docetaxel and Trastuzumab for the Treatment Of Untreated ErbB2 Over-Expressing Metastatic Breast Cancer Status TERMINATED Phase PHASE1
NCT00248482 Imatinib Mesylate After Irinotecan and Cisplatin in Treating Patients With Extensive-Stage Small Cell Lung Cancer Status COMPLETED Phase PHASE2
NCT00248170 Comparison Trial of Letrozole to Anastrozole in the Adjuvant Treatment of Postmenopausal Women With Hormone Receptor and Node Positive Breast Cancer Status COMPLETED Phase PHASE3
NCT00248157 Extension Study of the Long-term Safety and Tolerability of Octreotide Acetate in Patients With Moderately Severe or Severe Non-proliferative Diabetic Retinopathy or Low Risk Proliferative Diabetic Retinopathy Status TERMINATED Phase PHASE3
NCT00248131 Extension Study of Long-term Safety and Tolerability of Octreotide Acetate in Patients With Moderately Severe or Severe Non-proliferative Diabetic Retinopathy or Low Risk Proliferative Diabetic Retinopathy Status TERMINATED Phase PHASE3
NCT00247663 Extension Study of 1.0mg Dose Letrozole Therapy in Postmenopausal Patients With Breast Cancer Status COMPLETED Phase PHASE2
NCT00242580 A Safety and Efficacy Study Comparing the Combination Treatments of Verteporfin Therapy Plus One of Two Different Doses of Intravitreal Triamcinolone Acetonide and the Verteporfin Therapy Plus Intravitreal Pegaptanib Status COMPLETED Phase PHASE3
NCT00242567 Study of Zoledronic Acid for Patients With Hormone-sensitive Bone Metastases From Prostate Cancer Status COMPLETED Phase PHASE3
NCT00242554 Open-label Phase IV Clinical Trial to Evaluate the Safety and Tolerability of Zoledronic Acid in Patients With Prostate Cancer and Bone Metastases Status COMPLETED Phase PHASE4
NCT00242541 Study Assessing the Efficacy and Safety of Octreotide Acetate in Patients With Acromegaly, With Micro or Macroadenomas Status TERMINATED Phase PHASE4
NCT00241111 Assessment of the Efficacy, Tolerability and Pharmaco-economic Impact of Zoledronic Acid Treatment in Prostate Cancer With Bone Metastasis Status COMPLETED Phase PHASE4
NCT00241046 Letrozole in the Treatment of 1st and 2nd Line Hormone Receptor Positive Breast Cancer: Pre-therapeutic Risk Assessment Status TERMINATED Phase PHASE4
NCT00241020 Evaluation of the Efficacy of Long-acting Release Octreotide in Patients With Advanced Hepatocellular Carcinoma Status COMPLETED Phase PHASE3
NCT00240942 Letrozole in the Treatment of Severe and Recurrent Endometriosis Status COMPLETED Phase PHASE2
NCT00239902 Efficacy and Safety of FTY720 in de Novo Adult Renal Transplant Recipients Status COMPLETED Phase PHASE2
NCT00239876 Efficacy and Safety of FTY720 in de Novo Adult Renal Transplant Recipients Status COMPLETED Phase PHASE3
NCT00239863 Efficacy and Safety of FTY720 Versus Mycophenolate Mofetil (MMF, Roche Brand) in de Novo Adult Renal Transplant Recipients Status COMPLETED Phase PHASE3
NCT00239811 Long Term Efficacy and Safety of FTY720 in de Novo Adult Renal Transplant Recipients Status COMPLETED Phase PHASE3
NCT00239798 Efficacy and Safety of FTY720 in de Novo Adult Renal Transplant Recipients Status COMPLETED Phase PHASE2